Skip to content

A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.

A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/07/001890
Enrollment
50
Registered
2011-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: System A: Gillette Guard and Gillette NASP sensitive gel. Control Intervention1: System B: India leading double edge razor and India leading bar soap. Control Intervention2: System C: G

Sponsors

Procter and Gamble
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Indian men Age group of 18 to 45 years Subjects using double razor with bar soap only for shaving in the past 3 months. Subject having healthy facial skin. Subject willing to participate in the study. Subject willing to abide by and comply with the study protocol. Subject willing to give his consent for study participation.

Exclusion criteria

Exclusion criteria: Subject allergic to any shaving gel. Subjects having visible signs of facial irritation, allergy, sunburn, excessive tanning, or blotchy skin color Subject suffering from any facial skin diseases like allergic contact dermatitis, tinea faciei or tinea barbae, folliculitis (face), severe acne, rosacea, facial psoriasis or other cutaneous manifestations which could interfere with the study. Subject participated in any other similar investigation in the past 6 months.

Design outcomes

Primary

MeasureTime frame
To quantify the number of nicks and cuts experienced while shaving with Gillette Guard Razor and Gillette Shaving Gel compared to different shaving systems.Timepoint: The outcome will be measured after the completion 7 weeks (14 shavings) for each volunteer.

Secondary

MeasureTime frame
Not applicable.Timepoint: Not applicable.

Countries

India

Contacts

Public ContactDr Mukta Sachdev

Karnataka Medical Council

mukta.sachdev@mscr.in80-91-40917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026